Beyond Air Inc.

  • Home
  • About Us
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Technology
  • Pipeline
    • Overview
    • PPHN
    • Viral Lung Infections
    • Nontuberculous Mycobacteria (NTM)
    • Solid Tumors
  • News & Events
    • Press Releases
    • Presentations
    • Publications
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Company Info
    • Stock Data
    • SEC Filings
    • Governance
  • Careers
  • Contact

Publications

News & Events

News & Events

  • Press Releases
  • Presentations
  • Publications
  • Events
  • Email Alerts
R. Thomson, et al. (2022). Home-based Intermittent Inhaled High-Dose Nitric Oxide (NO) in Nontuberculous Mycobacterial Pulmonary Disease Using a Novel NO Generator and Delivery System is Safe and Well-Tolerated. American Thoracic Society Conference 2022 (ATS 2022). May 13-18, 2022.

R. Thomson, et al. (2022). Home-based Intermittent Inhaled High-Dose Nitric Oxide (NO) in Nontuberculous Mycobacterial Pulmonary Disease Using a Novel NO Generator and Delivery System is Safe and Well-Tolerated. American Thoracic Society Conference 2022 (ATS 2022). May 13-18, 2022.

A. Goldbart, et al. (2022) Long-term effects of inhaled nitric oxide in infants with bronchiolitis – a multi center study. Pediatric Academic Societies Meeting 2022 (PAS 2022).  April 21-25, 2022.

A. Goldbart, et al. (2022) Long-term effects of inhaled nitric oxide in infants with bronchiolitis – a multi center study. Pediatric Academic Societies Meeting 2022 (PAS 2022). April 21-25, 2022.

   T. Wolak, et al. (2022) Treatment of COVID-19 With Inhaled Nitric Oxide Using A Novel Nitric Oxide Generator. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022. April 23-26, 2022.

T. Wolak, et al. (2022) Treatment of COVID-19 With Inhaled Nitric Oxide Using A Novel Nitric Oxide Generator. 32nd European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) 2022. April 23-26, 2022.

Goldbart A et al. (2021) Non-tuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide. BMJ Case Rep. 2021 Oct 28

Goldbart A et al. (2021) Non-tuberculous mycobacteria infection treated with intermittently inhaled high-dose nitric oxide. BMJ Case Rep. 2021 Oct 28

Asher T. et al (2021) Efficacy and Safety of Inhaled Nitric Oxide for the Treatment of Acute Bronchiolitis: An Evaluation of Three Trials. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Asher T. et al (2021) Efficacy and Safety of Inhaled Nitric Oxide for the Treatment of Acute Bronchiolitis: An Evaluation of Three Trials. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Wolak T. et al (2021) Inhaled Nitric Oxide for the Treatment of COVID-19 and Other Viral Pneumonias in Adults. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Wolak T. et al (2021) Inhaled Nitric Oxide for the Treatment of COVID-19 and Other Viral Pneumonias in Adults. American Thoracic Society (ATS) 2021. May 14-19, 2021.

Confino H. et al (2020) Nitric Oxide Tumor Ablation Stimulates an Anti-Tumor Immune Response in Mice. American Association for Cancer Research (AACR) Conference on Tumor Immunology and Immunotherapy, October 19-20, 2020.

Confino H. et al (2020) Nitric Oxide Tumor Ablation Stimulates an Anti-Tumor Immune Response in Mice. American Association for Cancer Research (AACR) Conference on Tumor Immunology and Immunotherapy, October 19-20, 2020.

Goldshtein M. et al (2020). Nitric Oxide is a Powerful Anti-Coronavirus Inhaled Agent that Acts Within Hours. CHEST Annual Meeting, October 18-21, 2020.

Goldshtein M. et al (2020). Nitric Oxide is a Powerful Anti-Coronavirus Inhaled Agent that Acts Within Hours. CHEST Annual Meeting, October 18-21, 2020.

Goldbart A.  et al (2020). Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently via Inhalation to Subjects with Bronchiolitis – a Multi-Center Double Blind Study. CHEST Annual Meeting, October 18-21, 2020.

Goldbart A. et al (2020). Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently via Inhalation to Subjects with Bronchiolitis – a Multi-Center Double Blind Study. CHEST Annual Meeting, October 18-21, 2020.

Confino H. et al (2020). Nitric Oxide Lung Cancer Active Vaccination. 2020 North American Conference on Lung Cancer, October 16th.

Confino H. et al (2020). Nitric Oxide Lung Cancer Active Vaccination. 2020 North American Conference on Lung Cancer, October 16th.

RSS
  • 1
  • 2
  • 3
  • 4
  • Next »

Important Safety Information

†Caution - LungFit is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.

© 2022 Beyond Air Inc. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Search